{"meshTags":["Animals","Antibodies, Monoclonal","Antibodies, Monoclonal, Humanized","Antineoplastic Agents","Antineoplastic Combined Chemotherapy Protocols","Breast Neoplasms","Clinical Trials as Topic","Female","Heart","Humans","Neoplasm Metastasis","Receptor, ErbB-2","Trastuzumab"],"meshMinor":["Animals","Antibodies, Monoclonal","Antibodies, Monoclonal, Humanized","Antineoplastic Agents","Antineoplastic Combined Chemotherapy Protocols","Breast Neoplasms","Clinical Trials as Topic","Female","Heart","Humans","Neoplasm Metastasis","Receptor, ErbB-2","Trastuzumab"],"publicationTypes":["Journal Article","Review"],"title":"Herceptin: from the bench to the clinic.","pubmedId":"11291556"}